NCT06664177 Analgesic Efficacy of Quadratus Lumborum vs. Transversalis Fascia Block in Inguinal Hernia Surgery
| NCT ID | NCT06664177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Pain, Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-11-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is planned to compare the postoperative analgesic efficacy of the Transversalis Fascia Plane Block and the anterior Quadratus Lumborum Block in elective inguinal hernia surgeries.
Eligibility Criteria
Inclusion Criteria: * Ages 18-65 * ASA Classification 1-2 Exclusion Criteria: * Allergy to local anesthetics * Presence of infection at the procedure site * BMI \> 35 kg/m² * Bleeding disorders or anticoagulant use * Chronic analgesic or opioid use * Mental or psychiatric disorders * ASA Classification 3-4 patients(Severe COPD, history of cerebrovascular events, liver and kidney disease will be excluded from the study.)
Contact & Investigator
Serpil Sehirlioglu, MD
PRINCIPAL INVESTIGATOR
Gaziosmanpasa Research and Education Hospital
Frequently Asked Questions
Who can join the NCT06664177 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Pain, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06664177 currently recruiting?
Yes, NCT06664177 is actively recruiting participants. Contact the research team at drserpilsahin@gmail.com for enrollment information.
Where is the NCT06664177 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06664177 clinical trial?
NCT06664177 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is Serpil Sehirlioglu, MD at Gaziosmanpasa Research and Education Hospital. The trial plans to enroll 60 participants.